You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
27 March 2024
Uni-Bio Science Group Announces 2023 Annual Results
23 January 2024
Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)
22 January 2024
As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
28 August 2023
Uni-Bio Science Group Limited Announces 2023 Interim Results
27 March 2023
Uni-Bio Science Group Limited: 2022 Annual Results
29 August 2022
Uni-Bio Science Group Limited: 2022 Interim Results
29 June 2022
Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)
22 March 2022
Uni-Bio Science Group Limited：2021 Annual Results
1 April 2020
Uni-Bio Science Group Limited 2019 Annual Results Turnover Increased by 54.9% YoY to HK$209.4 million Recording EBITDA of HK$28.4 million Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020
13 January 2020
Great Bay Bio injected with 2.5 million USD of convertible note
18 October 2019
Great Bay Bio and Boji Medical have Reached Strategic Cooperation to Jointly Develop a Long-Acting Biological and Innovative Anti-Anemia Injection
30 August 2019
Uni-Bio Science Group Limited 2019 Interim Results Successful Turning Loss into Profit, Strong Release of Market Potential Sales of key products doubled, Business restructuring completed smoothly
27 August 2019
Great Bay Bio’s 3D Advisory Board Science Committee Welcomes Another New Arrival
12 August 2019
Great Bay Bio Adds Two Industry Leaders to Advisory Board
1 August 2019
Continuous Augmentation of Governance Structure The Board of Great Bay Bio Welcomes a New Member
18 April 2019
Uni-Bio Group (HK690)’s Uni-PTH (Teriparatide) High-Precision Industrialization Project Was Successfully Approved Focus on the Transformation of Major Frontier Achievements Targeting the Tens of Billions Osteoporosis Market
29 March 2019
Uni-Bio Science Group (0690.HK) – 2018 Annual Results Enhanced Market Penetration of Core Marketed Products Pipeline Products Witnessed a Steady Progress to Launch Commencement of CMO Service to Fully Harness Asset Values
